6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Behavioral Addiction Neurobiology
Behavioral addictions, such as gambling or internet use, share neurobiological features with substance use disorders. The neurobiology of behavioral addiction involves the activation of the brain's reward pathways, particularly the mesolimbic dopamine system, which drives compulsive behavior. When individuals engage in addictive behaviors, they experience a surge in dopamine release, leading to feelings of pleasure and reinforcing the behavior. Over time, repeated activation of these pathways can result in tolerance, where more of the behavior is needed to achieve the same rewarding effect, and withdrawal symptoms when the behavior is discontinued. Understanding the neurobiology of behavioral addiction has led to the development of pharmacological treatments aimed at modulating dopamine transmission, as well as behavioral interventions to address the psychological components of addiction.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States